Articles related to CONTINUING EDUCATION (CE)

In this CE program, unravel the mysteries of understanding lacrimal gland abnormalities, an essential topic for all practicing optometrists. Navigating lacrimal gland abnormalities is a crucial skill for optometrists. This comprehensive continuing education program enhances our ability to identify and manage such abnormalities effectively. At the core, understanding the anatomy of a healthy lacrimal gland lays the groundwork for spotting deviations. Lacrimal glands, situated in each orbit, are bi-lobed structures split by the levator palpebrae superioris tendon. Pain in patients with lacrimal gland disease often arises from the trigeminal nerve, with the autonomic nervous system handling gland innervation. Moving on, the primary function of these glands is tear production. As a result, any dysfunctions can lead to aqueous-deficient dry eye disease. The two broad categories of this condition include Sjögren’s syndrome (SS)-related and non-Sjögren’s conditions. SS often leads to lymphocyte infiltration into salivary and lacrimal glands, triggering dry mouth and eye symptoms. Alternatively, non-Sjögren’s conditions can stem from hormonal shifts, autoimmune diseases, and certain drugs. Interestingly, the lacrimal gland plays a secondary yet significant role in ocular immunity by producing antibodies. Its susceptibility to systemic conditions affecting immune responses calls for vigilant attention to detect abnormalities. Practical learning comes through […]

Discover a holistic perspective on advanced bladder and renal cell cancers management, encompassing everything from pathogenesis to adverse event mitigation. Let’s dive into the “Advanced Bladder and Renal Cell Cancers Management” webcast, released on April 30, 2023, offering valuable 1.00 ANCC contact hour, inclusive of 0.75 pharmacology hours. Presented by expert Mary W. Dunn, MSN, RN, OCN, NP-C from the University of North Carolina, this program targets oncology nurses, nurse navigators, advanced nursing providers, and nurses from other cancer-related subspecialties. It remains available until April 30, 2024, leaving ample time to gain this crucial knowledge. Primarily, this webcast zeroes in on bladder cancer (BC), a malignancy notorious for its high mortality rate, and renal cell carcinoma (RCC), a top-10 common cancer. Unfortunately, BC’s 5% survival rate for metastatic disease cases paints a grim picture. Luckily, hope emerges in the form of novel therapeutic agents for advanced, recurrent, and metastatic BC and RCC. Next, the program navigates through the pathogenesis of these cancers. Equipped with this knowledge, healthcare providers can better understand the intricacies of disease progression. As the treatment landscape rapidly evolves, so does the complexity in selection, sequencing, and adverse event (AE) management. Thus, the webcast outlines how to […]

The Institute of Medicine (IOM) has laid a crucial foundation in understanding medical errors. In their transformative report, they found that systems failure is frequently the culprit behind medical errors. The report highlighted that medical errors account for 98,000 deaths per year, while up to 220,000 lives could be saved annually if we address these errors. Recognizing the importance of risk management, healthcare organizations are taking strides to pinpoint, assess, and control risk and potential liability exposure. Considering the pivotal role that nurses play in risk management daily, it’s crucial that you are well informed about common patient safety risks, the reasons for medical errors, and how to reduce risk. The primary aim of this course is to deepen your understanding as a nursing professional in acute care of risk management. The course also equips you with practical risk-reduction tools to minimize your exposure to professional liability. Once you have completed this course, you should be equipped to: Be at the forefront of reducing medical errors and enhancing patient safety. By expanding your knowledge and skills in risk management, you can make a significant difference in patient outcomes and the healthcare landscape as a whole.

Following successful completion of this $39 three CE-credit course, the dental professional should be able to:

Pharmacogenomics (PGx) researches how germline (or inherited) alterations impact a person’s receptivity to medication. Almost everyone has a clinically significant variant of one or more pharmacogenes. Genetic variations in PK, PD, and HLA are linked to variations in drug response. Evidence only supports the utility of PGx testing for the four genes CYP2C19, CYP2D6, HLA-B15:02, and HLA-A31:01 in mental health. Fill out the CPE exam and submit it online at www.pharmacist.com/education if you’re interested in receiving 1 hour of CPE credit for this activity.

This activity is designed for optometrists managing ocular hypertension, and participants should be more adept at the following after completing it: